2019 NBDPN Annual Meeting

 
Watch the meeting: https://adobeconnect.cdc.gov/rnnthju6qaf1/
Tell us what you think of the meeting: https://www.surveymonkey.com/r/NBDPN2019AM

WD4190
 
PROGRAM DESCRIPTION: The training is designed to increase knowledge and change competency of current practices in birth defects surveillance and research to improve public health efforts to prevent birth defects. The 2019 NBDPN Virtual Meeting will cover topics in birth defects surveillance, research, and prevention to keep public health and medical professionals abreast of current issues affecting the field of birth defects. This new knowledge should aid them in understanding current national standards and guidelines for improving birth defects surveillance. Additionally, we will provide updates on data analysis methodologies, surveillance for chromosomal defects, and the use of electronic health records. This will be a multi-day virtual meeting composed of pre-recorded sessions. We will have eight speakers from organizations such as Centers of Disease Control and Prevention, Baylor College of Medicine, Boston University School of Public Health, and Michigan Department of Health.
 
OBJECTIVES:
 
At the conclusion of the session, the participant will be able to:
 
1. Describe the use of, and accuracy of, at least two genetic diagnostic methods.
2. Identify two pros and two cons between using data mining versus traditional analysis methods.
3. Describe the basic approach to calculating and interpreting p-values and confidence intervals.
4. Describe three concepts in leveraging health information exchange for public health surveillance.
5. Explain the difference between non-invasive screening and genetic testing and their implications for treatment.
6. Describe the importance of inter-professional collaboration in birth defects surveillance, research, and epidemiology.
 
FACULTY/CREDENTIALS:                                          
 
Clinton Alverson, MS, MS, Mathematical Statistician
Centers for Disease Control and Prevention
 
Georgetta Alverson, CTR, Birth Defects & Cancer Surveillance Section Manager Michigan Department of Health & Human Services
 
Melissa Danielson, MSPH, Statistician
Centers for Disease Control and Prevention
 
Sarah Obian, MD, Assistant Professor and Medical Director of MotherToBaby Florida
University of South Florida   
 
Julie Petersen, MPH (PhD Candidate), Statistical Analyst and Doctoral Student
Boston University School of Public Health   
 
Daniel Riconda, MS, CGC, Genetic Counseling Program Director
Baylor College of Medicine  
 
Angela Scheuerle, MD, FACMG, Professor, Department of Pediatrics, Division of Genetics and Metabolism, University of Texas Southwestern Medical Center                                                    
                                                                     
ORIGINATION DATE:                                May 1, 2019
                                  
EXPIRATION DATE:                                  May 1, 2021

URL                                                           https://adobeconnect.cdc.gov/rnnthju6qaf1/
 
HARDWARE/SOFTWARE:                       Computer Hardware; Internet connection; Browser
 
MATERIALS:                                              None
 
TARGET AUDIENCE:                                Administrators, Advance Practice Nurses, DOs, Epidemiologists, Licensed Practical/Vocational Nurses, MDs, Other Health Educators, Physician Assistants, Program Managers, Registered Nurses, Health Scientists

PREREQUISITES:                                      Basic knowledge about birth defects.
 
FORMAT:                                                   This content is web-on-demand
 
CONTACT INFORMATION: Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Division of Congenital and Developmental Disorders, 1-404-498-0205
 
ACCREDITATION STATEMENTS:

CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and the National Birth Defects Prevention Network. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians.
 
The Centers for Disease Control and Prevention designates this enduring material for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
 
CNE:  The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.
 
This activity provides 4.4 contact hours.
 
CEU:  The Centers for Disease Control and Prevention is authorized by IACET to offer 0.4 CEU's for this program.
 
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 4.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
 
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
 
CDC, our planners, our content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Russell Kirby and he wishes to disclose that he receives core funding as a Principle Investigator for University of South Florida Birth Defects Surveillance Program with funding from Florida Department of Health and Centers for Disease Control and Prevention, and that he is a consultant for March of Dimes, Tampa market Board of Directors, and with the exception of Mr. Daniel Riconda and he wishes to disclose that he served as a consultant to AstraZenecaTaiwan to provide genetic counseling training in Taiwan
 
Planning committee discussed conflict of interest with Dr. Russell Kirby and Mr. Daniel Riconda to ensure there is no bias.
 
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
 
The Centers for Disease Control and Prevention and National Birth Defects Prevention Network are jointly providing the CNE for this activity.
 
CDC did not accept commercial support for this continuing education activity.

Instructions for Obtaining Continuing Education (CE)
 
In order to receive continuing education (CE) for WD4190-2019 National Birth Defects Prevention Network Virtual Annual Meeting please visit TCEO and follow these 9 Simple Steps before May 1, 2021 
 
The course access code is NBDPN2019.
 
Complete the activity
Complete the Evaluation at www.cdc.gov/GetCE
Pass the posttest at 70% at www.cdc.gov/GetCE  
 
FEES: No fees are charged for CDC’s CE activities.